Accordingly, destabilizing TIM or disrupting the essential interactions of TIM at replication forks may provide a useful way to specifically target and kill cancer cells that have adapted to oncogene-induced replication stress or in part sensitize cancer cells to checkpoint inhibitors or cytotoxic chemotherapy. This evidence concerns the gene TIMELESS and cancer.